Incorporating Fecal Calprotectin in Clinical Practice for Patients with Moderate to Severely Active Ulcerative Colitis Treated with Biologics or Small Molecule Inhibitors

BACKGROUND: We applied the GRADE (Grading of Recommendations Assessment, Development and Evaluation) framework to evaluate the performance of fecal calprotectin (FC) as an alternative to endoscopy in patients with moderate-severe ulcerative colitis (UC) treated with a biologic agent or tofacitinib....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Gastroenterol
Autors principals: Dulai, Parambir S., Battat, Robert, Barsky, Maria, Nguyen, Nghia H., Ma, Christopher, Narula, Neeraj, Mosli, Mahmoud, Casteele, Niels Vande, Boland, Brigid S., Prokop, Larry, Murad, M. Hassan, D’Haens, Geert, Feagan, Brian G., Sandborn, William J., Jairath, Vipul, Singh, Siddharth
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7274901/
https://ncbi.nlm.nih.gov/pubmed/32384283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14309/ajg.0000000000000596
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars